Post Tonsillectomy Analgesia Comparison After Surgery Site Spray of Local Anesthesics
NCT ID: NCT04325113
Last Updated: 2020-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2019-02-07
2020-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravenous Lidocaine in the Prevention of Postoperative Vomiting in Elective Tonsil Surgery
NCT01986309
The Effect of Intravenous Lidocaine on Pain After Tonsillectomy
NCT01291979
Peri Tonsillar Infiltration of Ketamine or Bupivacaine for Post Tonsillectomy Analgesia
NCT05341323
Suprazygomatic Nerve Block in Tonsillectomy Patients
NCT06359925
Levobupivacaine vs Levobupivacaine + Dexmedetomidine Infiltration for Post-tonsillectomy Analgesia and Laryngospasm in Pediatric Patients
NCT04113720
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NaCl 0,9%
patients receive 5ml of NaCl 0,9% at the level of the tonsils lodge
levobupivacaine
Patient satisfaction and pain score using a visual anagogic scale (VAS)
Xylocaine 2%
patients receive 5ml of Xylocaïne 2% at the level of the tonsils lodge
levobupivacaine
Patient satisfaction and pain score using a visual anagogic scale (VAS)
Levobupivacaine 0,5%
patients receive 5ml of Levobupivacaine 0,5% at the level of the tonsils lodge
levobupivacaine
Patient satisfaction and pain score using a visual anagogic scale (VAS)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
levobupivacaine
Patient satisfaction and pain score using a visual anagogic scale (VAS)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetes
* Kidney failure
* Chronic pain and fibromyalgia
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin Javillier
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Javillier
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tonsilstopic
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.